LUCIDICOR, INC.

Basic Information

480 S HORIZON WAY
BRANCHBURG, NJ, 08853-4026

Company Profile

n/a

Additional Details

Field Value
DUNS: 832807163
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 3


  1. NIH Phase II-UNCD as Bio-Inert Interface for Anti-Thrombogenicity Applications in

    Amount: $192,034.00

    DESCRIPTION: Protein kinases are chemically tractable drug targets, yet less than 5% of the human kinome has been thoroughly explored with selective small molecule inhibitors to demonstrate their th ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. SBIR Phase I: Development of Fluorescent Probes for Protein Phosphorylation

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project proposes to optimize and market a genetically-encoded fluorescent biosensor responsive to protein phosphorylation. This product is based ...

    SBIR Phase I 2011 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government